source
- Radiology practices increasingly develop and market in-house AI, branding themselves as AI-nativeRadiology groups, especially outpatient and teleradiology firms, are moving beyond using third‑party AI tools and are building their own algorithms within the practice. By keeping development in‑h…
- EMA leaders say single pivotal trial should not be default, decision must match evidence neededEMA chief Emer Cooke and other officials weighed in on the ongoing debate about the number of pivotal trials required for drug approval. They argued that requiring a single pivotal trial as a rigi…